Company news

Enanta Pharmaceuticals, Inc. news in 2021

Enanta Pharmaceuticals, Inc.'s news releases, calls and decks from 2021, newest first.

View company

Enanta Pharmaceuticals Reports Financial Results for its Fiscal Fourth Quarter and Year Ended September 30, 2021 with Webcast and Conference Call Today at 4: 30 p.m. ET

November 21, 2021

Enanta Pharmaceuticals Announces Update to its Hepatitis B Virus (HBV) Program

November 17, 2021

Enanta Pharmaceuticals Reports Positive Final Data from its Phase 1b Studies of EDP-514, a Novel Hepatitis B Virus Core Inhibitor

November 11, 2021

Enanta Pharmaceuticals Provides Update on NASH FXR Agonist Programs

October 3, 2021

Enanta Pharmaceuticals Announces Data Presentations at AASLD’s The Liver Meeting® 2021

September 30, 2021

Enanta Pharmaceuticals Elects Yujiro S. Hata to its Board of Directors

August 22, 2021

Enanta Pharmaceuticals Doses First Subject in a Phase 1 Clinical Study of EDP-721, Its Oral Hepatitis B Virus RNA Destabilizer

August 15, 2021

Enanta Pharmaceuticals Reports Financial Results for Its Fiscal Third Quarter Ended June 30, 2021 with Webcast and Conference Call Today at 4: 30 p.m. ET

August 4, 2021

Enanta Pharmaceuticals Announces Nomination of Clinical Candidate EDP-235, its Lead Oral Protease Inhibitor Specifically Designed for the Treatment of COVID-19

August 4, 2021

Enanta Pharmaceuticals Announces the Planned Retirement of Chief Medical Officer Nathalie Adda, M.D.

July 13, 2021

Enanta Pharmaceuticals Reports Positive Data from Phase 1b Study of EDP-514, a Hepatitis B Virus (HBV) Core Inhibitor, in Viremic Chronic HBV Patients

June 21, 2021

Enanta Pharmaceuticals Reports Positive Data from Part 2 of its Phase 1b Study of EDP-514 in Chronic Hepatitis B Virus Patients on Treatment with a Nucleoside Reverse Transcriptase Inhibitor

May 5, 2021

Enanta Pharmaceuticals Reports Financial Results for its Fiscal Second Quarter Ended March 31, 2021 with Webcast and Conference Call Today at 4: 30 p.m. ET

May 5, 2021

Enanta Pharmaceuticals Reports Financial Results for its Fiscal First Quarter Ended December 31, 2020 with Webcast and Conference Call Today at 4: 30 p.m. ET

February 7, 2021

Enanta Pharmaceuticals Announces the Appointment of Brendan Luu as Senior Vice President, Business Development

January 25, 2021

Enanta Pharmaceuticals Announces the Appointment of John P. DeVincenzo, M.D. as Vice President of Translational Virology

January 4, 2021

Calls in 2021